Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing IN Gammopathy Patients (SHIVERING Trial)
Phase of Trial: Phase I
Latest Information Update: 30 Aug 2016
Price : $35 *
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms SHIVERING Trial
- 31 Aug 2018 Biomarkers information updated
- 24 Aug 2016 Status changed from active, no longer recruiting to completed.
- 14 Jul 2015 Planned End Date changed from 1 Aug 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.